Invitation to Qlife Q1 2021 report presentation May 5, 2021
Qlife will publish its Q1 report for 2021 on May 5, at 08:00 CET.
A presentation of the report will be held the same day at 10:30 CET via audiocast.
Qlife invites investors, financial analysts and the media to a presentation where Thowas Warthoe will comment on the report. The report will be released at 08:00 and will be available at https://qlifeholding.com/sv/investerare/finansiella-rapporter
The presentation will be held in English at 10:30 CET and will be followed by a Q&A session.
To participate at the presentation
If you wish to participate via teleconference, please click on the link below for call details.
Dial-in number DE: +4578723252 SE: +46850558365 UK: +443333009269 US: +18338230590
After the presentation a recording of the webcast will be available at the same page.
For more information please contact:
Thomas Warthoe, CEO
+45 21 63 35 34
Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement.
Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: email@example.com).